CloudMD to Report First Quarter Financial Results on Monday, May 30, 2022
CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF) will release its Q1 2022 financial results on May 30, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF) will release its Q1 2022 financial results on May 30, 2022, after market close. A conference call is scheduled for May 31, 2022, at 9:00 AM ET to discuss these results. The company aims to transform healthcare delivery through technology, providing a patient-centric approach with services including telemedicine and mental health support. CloudMD currently serves over 5,700 clinicians and covers 12 million lives across North America.
Positive
- Expansion of services through technology with a patient-centric approach.
- Serving over 5,700 clinicians, including 1,800+ mental health practitioners.
- Covers 12 million individual lives across North America.
Negative
- None.
Details
News Market Reaction – DOCRF
The recorded move for DOCRF in the trading session of this news was -11.17%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
VANCOUVER, British Columbia, May 24, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (“CloudMD” or the “Company”), a healthcare technology and innovative health services company transforming the delivery of care, announced today that the Company will release its financials results for the first quarter of 2022 on Monday, May 30, 2022 after market close.
CloudMD will hold its Q1 2022 earnings conference call and webinar on Tuesday, May 31, 2022 at 9:00am ET (6:00am PT).
Conference call and webinar details:
Date and Time: Tuesday, May 31, 2022 at 9:00am Eastern Time (6:00am Pacific Time)
Toll-Free Dial-In Number: (833) 562-0117
International Dial-In Number: (661) 567-1009
Webcast Link: https://edge.media-server.com/mmc/p/2popizyz
A link to the live event, as well as the financial statements and MD&A will be available on the Financial Statements page of the Company’s website.
About CloudMD Software & Services
CloudMD is transforming the delivery of healthcare using technology and by providing a patient-centric approach, with an emphasis on continuity of care. By leveraging healthcare technology, the Company is building one, connected platform that addresses all points of a patient’s healthcare journey and provides better access to care and improved outcomes. Through CloudMD’s proprietary technology, the Company delivers quality healthcare through a holistic offering including hybrid primary care clinics, specialist care, telemedicine, mental health support, healthcare navigation, educational resources, and artificial intelligence (AI). CloudMD’s business is separated into three main divisions: Clinics and Pharmacies, Digital Solution and Enterprise Health Solutions, the Company’s fastest growing division. CloudMD’s Enterprise Health Solutions Division has built a leading employer healthcare solutions, including its Comprehensive Integrated Health Services Platform, which offers one comprehensive, digitally connected platform for educational institutions, corporations, insurers, and advisors to better manage the health and wellness of their students, employees, and customers.
CloudMD currently services a direct ecosystem of over 5,700 clinicians including, 1,800+ mental health practitioners, 1,600+ allied health professionals, 1,400+ doctors and nurses and covers 12 million individual lives across North America. For more information visit: https://investors.cloudmd.ca.
ON BEHALF OF THE BOARD OF DIRECTORS
“Karen Adams”
Interim Chief Executive Officer
FOR ADDITIONAL INFORMATION CONTACT:
Julia Becker
VP, Investor Relations
julia@cloudmd.ca
(604)785-0850
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.